Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study

SIMPLE SUMMARY: Tebentafusp has recently been approved for the treatment of metastatic uveal melanoma (mUM). We performed a retrospective, multicenter study to analyze the outcomes and safety of tebentafusp therapy in 78 patients with mUM. Patients treated with tebentafusp had a median PFS of 3 mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomsitz, Dirk, Ruf, Theresa, Heppt, Markus, Staeger, Ramon, Ramelyte, Egle, Dummer, Reinhard, Garzarolli, Marlene, Meier, Friedegund, Meier, Eileen, Richly, Heike, Gromke, Tanja, Siveke, Jens T., Franklin, Cindy, Klespe, Kai-Christian, Mauch, Cornelia, Kilian, Teresa, Seegräber, Marlene, Schilling, Bastian, French, Lars E., Berking, Carola, Heinzerling, Lucie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341126/
https://www.ncbi.nlm.nih.gov/pubmed/37444540
http://dx.doi.org/10.3390/cancers15133430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341126/
https://www.ncbi.nlm.nih.gov/pubmed/37444540
http://dx.doi.org/10.3390/cancers15133430

Ejemplares similares